Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. JAMA Cardiol. 2017 08 01; 2(8):855-862.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Acute Coronary Syndrome
Aged
Aged
Angina, Unstable
Angina, Unstable
Antineoplastic Agents, Phytogenic
Antineoplastic Agents, Phytogenic
Drug-Eluting Stents
Drug-Eluting Stents
Everolimus
Everolimus
Female
Female
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Middle Aged
Middle Aged
Mortality
Mortality
Myocardial Infarction
Myocardial Infarction
Myocardial Revascularization
Myocardial Revascularization
Non-ST Elevated Myocardial Infarction
Non-ST Elevated Myocardial Infarction
Paclitaxel
Paclitaxel
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Proportional Hazards Models
Proportional Hazards Models
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Recurrence
Recurrence
Sirolimus
Sirolimus
ST Elevation Myocardial Infarction
ST Elevation Myocardial Infarction
Treatment Outcome
Treatment Outcome
authors with profiles
Usman Baber